ID: ALA4171156

Max Phase: Preclinical

Molecular Formula: C24H28Cl2N6O7

Molecular Weight: 583.43

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1[nH]c(C(=O)Nc2ccc(C(=O)N[C@@H](C)c3n[nH]c(=O)o3)cc2OCCNC(=O)OC(C)(C)C)c(Cl)c1Cl

Standard InChI:  InChI=1S/C24H28Cl2N6O7/c1-11-16(25)17(26)18(28-11)20(34)30-14-7-6-13(19(33)29-12(2)21-31-32-23(36)38-21)10-15(14)37-9-8-27-22(35)39-24(3,4)5/h6-7,10,12,28H,8-9H2,1-5H3,(H,27,35)(H,29,33)(H,30,34)(H,32,36)/t12-/m0/s1

Standard InChI Key:  ATPZHMVWATVBIK-LBPRGKRZSA-N

Associated Targets(non-human)

DNA gyrase subunit B 290 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Staphylococcus aureus 210822 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Enterococcus faecalis 29875 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Escherichia coli 133304 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Pseudomonas aeruginosa 123386 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 583.43Molecular Weight (Monoisotopic): 582.1397AlogP: 3.95#Rotatable Bonds: 9
Polar Surface Area: 180.44Molecular Species: NEUTRALHBA: 8HBD: 5
#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 6.94CX Basic pKa: CX LogP: 3.16CX LogD: 2.70
Aromatic Rings: 3Heavy Atoms: 39QED Weighted: 0.23Np Likeness Score: -1.32

References

1. Durcik M, Lovison D, Skok Ž, Durante Cruz C, Tammela P, Tomašič T, Benedetto Tiz D, Draskovits G, Nyerges Á, Pál C, Ilaš J, Peterlin Mašič L, Kikelj D, Zidar N..  (2018)  New N-phenylpyrrolamide DNA gyrase B inhibitors: Optimization of efficacy and antibacterial activity.,  154  [PMID:29778894] [10.1016/j.ejmech.2018.05.011]

Source